Pesquise e encontre o CMO / CDMO de que precisa
Descubra parceiros altamente qualificados para o seu projeto de desenvolvimento e fabrico de medicamentos.
Pharmaron API Commercial Synthesis Shaoxing (China)
Pharmaron
Síntese comercial de pequenas moléculas/peptídeos de API.
TAMANHO DO LOTE: Small, Medium, Large
ÁREAS DE EXPERIÊNCIA TERAPÊUTICA (ATC): (R) Respiratory system, (V09-10) Radiopharmaceuticals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (V01) Allergens, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (V04) Diagnostic agents, (S) Sensory organs, (G) Genito urinary system and sex hormones, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (B) Blood and blood forming organs, (V06) Nutrients
USAR: Human, Veterinary
SERVIÇOS: Analytical / QC services, Manufacturing services, Regulatory services, Development services, Quality Assurance services
REGIÃO: APAC
OEB (Faixas de Exposição Ocupacional): 2 (PDE = 1,000 - 10,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)
MERCADOS: FDA (USA), NMPA (China)
CONFORMIDADE: FDA (cGMP), NMPA (China GMP), ISO
CATEGORIA / PRODUTO: QUÍMICO-SINTÉTICO
MERCADOS: DIGEMID (Peru), ANMAT (Argentina), Turkish Health Authorities, EDE (UAE), Rest of World, ANVISA (Brazil), ISP (Chile), PMDA (Japan), FDA (USA), MSPAS (Guatemala), CDSCO (India), EMA (EU), COFEPRIS (Mexico), MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia), NMPA (China), Health Canada (Canada), INVIMA (Colombia), MHRA (UK)
TAMANHO DO LOTE: Small, Medium, Large
ÁREAS DE EXPERIÊNCIA TERAPÊUTICA (ATC): (R) Respiratory system, (V01) Allergens, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (V04) Diagnostic agents, (S) Sensory organs, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (N) Nervous system, (B) Blood and blood forming organs, (V06) Nutrients
CATEGORIA / PRODUTO: SERVIÇOS, OLIGONUCLEOTÍDEOS, QUÍMICO-SINTÉTICO
USAR: Human
CONFORMIDADE: ANVISA (Brazil B-GMP), NMPA (China GMP)
SERVIÇOS: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services
REGIÃO: APAC
OEB (Faixas de Exposição Ocupacional): 2 (PDE = 1,000 - 10,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)
Apeloa Pharmaceutical Co., Ltd.
Apeloa Pharmaceutical Co., Ltd
Apeloa CDMO fornece serviços de descoberta, desenvolvimento e fabricação de classe mundial para APIs, intermediários e RSMs.
MERCADOS: DIGEMID (Peru), ANMAT (Argentina), Turkish Health Authorities, EDE (UAE), ANVISA (Brazil), ISP (Chile), PMDA (Japan), FDA (USA), MSPAS (Guatemala), CDSCO (India), Russian Health Authorities, EMA (EU), COFEPRIS (Mexico), MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia), NMPA (China), Health Canada (Canada), INVIMA (Colombia), MHRA (UK)
TAMANHO DO LOTE: Small, Medium, Large
CONFORMIDADE: EMA (EU GMP), PMDA/MHLW (Japan GMP), World Health Organization (GMP / HACCP), FDA (cGMP), NMPA (China GMP), ECOVADIS, ISO
USAR: Human, Veterinary
SERVIÇOS: Analytical / QC services, Manufacturing services, Regulatory services, Development services, Packaging
REGIÃO: APAC
OEB (Faixas de Exposição Ocupacional): 2 (PDE = 1,000 - 10,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)
CATEGORIA / PRODUTO: QUÍMICO-SINTÉTICO
Sichuan Huiyu Pharmaceuticals Co., Ltd. - API Manufacturing Site
Seacross Pharmaceutical Co Ltd
Como um dos três locais principais, juntamente com o centro de P&D e a fábrica de formulação, nossa unidade de fabricação de API desempenha um papel vital na ca
MERCADOS: DIGEMID (Peru), ANMAT (Argentina), Turkish Health Authorities, EDE (UAE), Rest of World, ANVISA (Brazil), ISP (Chile), PMDA (Japan), FDA (USA), MSPAS (Guatemala), CDSCO (India), Russian Health Authorities, EMA (EU), COFEPRIS (Mexico), MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia), NMPA (China), Health Canada (Canada), INVIMA (Colombia), MHRA (UK)
TAMANHO DO LOTE: Small, Medium, Large
ÁREAS DE EXPERIÊNCIA TERAPÊUTICA (ATC): (R) Respiratory system, (V09-10) Radiopharmaceuticals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (V01) Allergens, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (V04) Diagnostic agents, (S) Sensory organs, (G) Genito urinary system and sex hormones, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (B) Blood and blood forming organs, (V06) Nutrients
CONFORMIDADE: ISP (Chile BPM), Roszdravnadzor (Russia GMP), ANMAT (Argentina nueva GMP), EMA (EU GMP), PMDA/MHLW (Japan GMP), IFS, DIGEMID, UAE Ministry of Health & Prevention, ANVISA (Brazil B-GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), French Service-Public (CIR), TGA (Australia GMP), FDA (cGMP), NSF, NMPA (China GMP), SFDA (Saudi Food & Drug Authority), BRCGS, ECOVADIS, ISO, Halal Research Council, INVIMA, Health Canada (Canada GMP), SQF (Safe Quality Food), TITCK (Turkish Health Authorities), MSPAS, MFDS/KFDA (Republic of Korea GMP), COFEPRIS
SUBSTÂNCIAS CONTROLADAS: Lowest potential for abuse, High potential for abuse & no medical use, High potential for abuse & medical use, Lower potential for abuse, Low potential for abuse
BSL (Nível de Segurança Biológica): 3, 4, 1, 2
USAR: Human
SERVIÇOS: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services
REGIÃO: APAC
OEB (Faixas de Exposição Ocupacional): 2 (PDE = 1,000 - 10,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)
CATEGORIA / PRODUTO: QUÍMICO-SINTÉTICO
Sichuan Huiyu Pharmaceuticals Co., Ltd. - R&D Site
Seacross Pharmaceutical Co Ltd
O Centro de P&D desempenha um papel fundamental no apoio ao desenvolvimento tanto de APIs quanto de formas farmacêuticas acabadas.
MERCADOS: DIGEMID (Peru), ANMAT (Argentina), Turkish Health Authorities, EDE (UAE), Rest of World, ANVISA (Brazil), ISP (Chile), PMDA (Japan), FDA (USA), MSPAS (Guatemala), CDSCO (India), Russian Health Authorities, EMA (EU), COFEPRIS (Mexico), MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia), NMPA (China), Health Canada (Canada), INVIMA (Colombia), MHRA (UK)
TAMANHO DO LOTE: Small, Medium, Large
ÁREAS DE EXPERIÊNCIA TERAPÊUTICA (ATC): (R) Respiratory system, (V09-10) Radiopharmaceuticals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (V01) Allergens, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (V04) Diagnostic agents, (S) Sensory organs, (G) Genito urinary system and sex hormones, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (B) Blood and blood forming organs, (V06) Nutrients
CATEGORIA / PRODUTO: FDF / MEDICAMENTOS, QUÍMICO-SINTÉTICO
CONFORMIDADE: ISP (Chile BPM), Roszdravnadzor (Russia GMP), ANMAT (Argentina nueva GMP), EMA (EU GMP), PMDA/MHLW (Japan GMP), IFS, DIGEMID, UAE Ministry of Health & Prevention, ANVISA (Brazil B-GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), French Service-Public (CIR), TGA (Australia GMP), FDA (cGMP), NSF, NMPA (China GMP), SFDA (Saudi Food & Drug Authority), BRCGS, ECOVADIS, ISO, Halal Research Council, INVIMA, Health Canada (Canada GMP), SQF (Safe Quality Food), TITCK (Turkish Health Authorities), MSPAS, MFDS/KFDA (Republic of Korea GMP), COFEPRIS
SUBSTÂNCIAS CONTROLADAS: Lowest potential for abuse, High potential for abuse & no medical use, High potential for abuse & medical use, Lower potential for abuse, Low potential for abuse
BSL (Nível de Segurança Biológica): 3, 4, 1, 2
USAR: Human
SERVIÇOS: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services
REGIÃO: APAC
OEB (Faixas de Exposição Ocupacional): 2 (PDE = 1,000 - 10,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)
Sichuan Huiyu Pharmaceuticals Co., Ltd. - Formulation Manufacturing Site
Seacross Pharmaceutical Co Ltd
O Centro de Fabricação de Formulações é dedicado ao desenvolvimento e produção de formas farmacêuticas complexas e de alto valor.
MERCADOS: DIGEMID (Peru), ANMAT (Argentina), Turkish Health Authorities, EDE (UAE), Rest of World, ANVISA (Brazil), ISP (Chile), PMDA (Japan), FDA (USA), MSPAS (Guatemala), CDSCO (India), Russian Health Authorities, EMA (EU), COFEPRIS (Mexico), MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia), NMPA (China), Health Canada (Canada), INVIMA (Colombia), MHRA (UK)
TAMANHO DO LOTE: Small, Medium, Large
ÁREAS DE EXPERIÊNCIA TERAPÊUTICA (ATC): (R) Respiratory system, (H) Systemic hormonal preparations excl. sex hormones and insulins, (V01) Allergens, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (V04) Diagnostic agents, (S) Sensory organs, (G) Genito urinary system and sex hormones, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (A) Digestive tract and metabolism, (D) Dermatologicals, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (B) Blood and blood forming organs, (V06) Nutrients
CATEGORIA / PRODUTO: FDF / MEDICAMENTOS, SERVIÇOS
CONFORMIDADE: ISP (Chile BPM), Roszdravnadzor (Russia GMP), ANMAT (Argentina nueva GMP), EMA (EU GMP), PMDA/MHLW (Japan GMP), IFS, DIGEMID, UAE Ministry of Health & Prevention, ANVISA (Brazil B-GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), French Service-Public (CIR), TGA (Australia GMP), FDA (cGMP), NSF, NMPA (China GMP), SFDA (Saudi Food & Drug Authority), BRCGS, ECOVADIS, ISO, Halal Research Council, INVIMA, Health Canada (Canada GMP), SQF (Safe Quality Food), TITCK (Turkish Health Authorities), MSPAS, MFDS/KFDA (Republic of Korea GMP), COFEPRIS
SUBSTÂNCIAS CONTROLADAS: Lowest potential for abuse, High potential for abuse & no medical use, High potential for abuse & medical use, Lower potential for abuse, Low potential for abuse
BSL (Nível de Segurança Biológica): 3, 4, 1, 2
USAR: Human
SERVIÇOS: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services
REGIÃO: APAC
OEB (Faixas de Exposição Ocupacional): 2 (PDE = 1,000 - 10,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)
CDMO/CMO facility
MAI network supplier
Serviços de P&D de peptídeos B2B e OEM/ODM para marcas e fabricantes de cosméticos.
Localização disponível após o registo
CDMO/CMO facility
MAI network supplier
Serviços de P&D de peptídeos B2B e OEM/ODM para marcas e fabricantes de cosméticos.
Localização disponível após o registo
FDF / MEDICAMENTOS manufacturing site
MAI network supplier
Soluções CDMO completas para intermediários APl e Key.
Localização disponível após o registo
Estas instalações correspondem aos seus critérios principais, mas nem todos os filtros opcionais.
SENN India | Non-GMP Plant | Hyderabad, India
Senn Chemicals
Local de fabricação não GMP em grande escala para intermediários peptídicos, síntese orgânica, operações LPPS e aumento de produção.
TAMANHO DO LOTE: Small, Medium, Large
CATEGORIA / PRODUTO: COSMÉTICOS, SERVIÇOS, ENGENHARIA DE PARTÍCULAS, QUÍMICO-SINTÉTICO
SERVIÇOS: Analytical / QC services, Logistics, Manufacturing services, Regulatory services, Development services, Packaging, Quality Assurance services
REGIÃO: APAC
SENN India | R&D Lab | Hyderabad, India
Senn Chemicals
Centro de P&D para peptídeos e química orgânica com SPPS, purificação, liofilização, análise e suporte de engenharia de partículas.
TAMANHO DO LOTE: Small
SERVIÇOS: Analytical / QC services, Logistics, Development services, Packaging, Quality Assurance services
REGIÃO: APAC
CATEGORIA / PRODUTO: ENGENHARIA DE PARTÍCULAS, QUÍMICO-SINTÉTICO
Viswa Laboratories Pvt Ltd
Viswa Laboratories Private Limited
CRAMS/CDMO, APIs, intermediários e especialidades químicas.
TAMANHO DO LOTE: Small, Medium, Large
ÁREAS DE EXPERIÊNCIA TERAPÊUTICA (ATC): (R) Respiratory system, (M) Musculoskeletal system, (J) Antiinfectives for systemic use, (C) Cardiovascular system, (D) Dermatologicals
SUBSTÂNCIAS CONTROLADAS: Lowest potential for abuse, Lower potential for abuse, Low potential for abuse
MERCADOS: ANVISA (Brazil), CDSCO (India), Russian Health Authorities, EMA (EU), NMPA (China)
USAR: Human, Veterinary
CONFORMIDADE: World Health Organization (GMP / HACCP)
REGIÃO: APAC
OEB (Faixas de Exposição Ocupacional): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)
SERVIÇOS: Manufacturing services, Development services
BSL (Nível de Segurança Biológica): 1, 2
CATEGORIA / PRODUTO: QUÍMICO-SINTÉTICO
Mais instalações na rede
Registe-se para desbloquear o catálogo completo com detalhes de contacto e locais.
+5 mais instalações
Criar Conta GRATUITA